Skip to main content

Day: July 6, 2020

Formpipe förvärvar det engelska mjukvarubolaget EFS

Formpipe förvärvar EFS Technology Ltd. (EFS) som under många år varit en framgångsrik försäljningspartner för Formpipes produkt Lasernet. I och med affären ökar Formpipe sin kapacitet att bygga ett större nätverk av kompetenta partners inom privat sektor. EFS omsättning för 2019 uppgick till 3,4 miljoner brittiska pund.Formpipe förvärvar 100 % av aktierna i EFS. Förvärvet förväntas slutföras per 31 juli. Köpeskillingen uppgår till 6 miljoner brittiska pund (GBP), motsvarande ett beräknat Enterprise Value på cirka 5 MGBP som betalas i samband med övertagandet och finansieras genom en kombination av egen kassa och lån. EFS omsättning för räkenskapsåret 2019 uppgick till 3,4 MGBP, varav drygt hälften består av repetitiva intäkter i form av support- och underhållsavtal. Förvärvet bedöms ha viss positiv påverkan på Formpipes resultat per aktie...

Continue reading

VILMORIN & CIE PURSUES THE OPTIMIZATION OF ITS FINANCIAL RESOURCES BY LAUNCHING A TENDER OFFER TO REPURCHASE ITS BOND

Vilmorin & Cie today announced the launch of a cash tender offer to repurchase its bond issue of a total nominal amount of 450 million euros, maturing in May 2021 (ISIN FR0011921881). This tender offer is scheduled to close on July 10, 2020.The maximum amount of the offer will be announced to bondholders on July 13, 2020 with settlement and delivery planned for July 15, 2020.Through this operation, Vilmorin & Cie’s objective is to anticipate its financial maturities and to pursue its strategy of optimizing its financial capacities.Vilmorin & Cie is accompanied for this transaction by CACIB and Natixis as dealer managers.COMING DISCLOSURES AND EVENTSMonday August 3, 2020(1): Disclosure of sales for fiscal year 2019-2020Wednesday October 14, 2020(1): Disclosure of results for fiscal year 2019-2020Monday November 2,...

Continue reading

VILMORIN & CIE POURSUIT L’OPTIMISATION DE SES RESSOURCES FINANCIÈRES EN LANÇANT UNE OFFRE DE RACHAT SUR SA SOUCHE OBLIGATAIRE

Vilmorin & Cie annonce le lancement ce jour d’une offre de rachat en numéraire portant sur son emprunt obligataire d’un montant nominal total de 450 millions d’euros, arrivant à maturité en mai 2021 (ISIN FR0011921881). La clôture de l’offre de rachat est prévue pour le 10 juillet 2020.Le montant maximum de l’offre sera annoncé aux porteurs obligataires le 13 juillet 2020 avec un règlement-livraison prévu le 15 juillet 2020.L’objectif de Vilmorin & Cie, au travers de cette opération, est d’anticiper ses échéances financières et de poursuivre sa stratégie d’optimisation de ses capacités financières.Vilmorin & Cie est accompagnée pour cette opération par CACIB et Natixis en qualité de teneurs de livre.PROCHAINS RENDEZ-VOUSLundi 3 août 2020(1) : Publication du chiffre d’affaires annuel 2019-2020Mercredi 14 octobre 2020(1) :...

Continue reading

Safe-T Group Ltd. Estimates 162%-168% Growth in Revenues in the First Half of 2020

HERZLIYA, Israel, July 06, 2020 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments, today provided an estimated revenue range for the second quarter of 2020 and for the six-month period ended June 30, 2020.On a preliminary basis, Safe-T expects to report revenue for the six-month period ended June 30, 2020 in the range of $2.15 million to $2.2 million, an increase in the range of 162% to 168%, respectively, compared to $0.821 million during the equivalent period in 2019. On a preliminary basis, Safe-T’s second quarter 2020 revenue is expected to be in the range between $1.05 million to $1.1 million, an increase in the range of 166% to 179%, respectively, compared to $0.394 million in the second quarter of 2019.Also, Safe-T reports that since...

Continue reading

Cegedim Insurance Solutions lance BEYOND : le 1er Hub de services pour l’assurance de personnes

Une solution modulaire et innovante répondant aux enjeux santé et prévoyance de tous les acteurs du secteurBoulogne-Billancourt, le 06 juillet 2020Cegedim Insurance Solutions, acteur majeur des solutions logicielles et services en santé et prévoyance, annonce le lancement de BEYOND, le 1er Hub de services “nouvelle génération” qui répond aux besoins métiers des acteurs de l’assurance de personnes.Dans un secteur en pleine transformation, marqué par des facteurs à la fois structurels (cadre réglementaire contraignant, évolution des besoins des assurés, etc.) et conjoncturels (émergence de nouveaux acteurs, hyper connectivité, digitalisation des offres, …), les acteurs de l’assurance de personnes doivent faire face à des enjeux stratégiques importants.Lorsque l’on sait que 71% des assurés* souhaitent se simplifier la vie et...

Continue reading

Approval of the Draft Safeguard Plan by the Creditors’ Committee

PRESS RELEASEAPPROVAL OF THE DRAFT SAFEGUARD PLAN BY THE CREDITORS’ COMMITTEEParis (France), 6 July 2020 – Technicolor (Euronext Paris: TCH; OTCQX: TCLRY) (the « Company ») and SELARL FHB, represented by Me Hélène Bourbouloux and Gaël Couturier, in their capacity as judicial administrators appointed as such by a ruling of the commercial court of Paris dated 22 June 2020 (the « Judicial Administrator »), herein announce that, in the framework of the meeting held on 5 July 2020 and convened by the Judicial Administrator, the lenders’ committee under the accelerated financial safeguard procedure, approved the draft safeguard plan at a majority of 100% of the creditors who cast a vote.This is a significant milestone for the Company, and the next key milestone will be the Shareholders Meeting which will be held on 20th July 2020 behind...

Continue reading

Adoption du projet de plan de sauvegarde par le comité des créanciers

 COMMUNIQUE DE PRESSEADOPTION DU PROJET DE PLAN DE SAUVEGARDE PAR LE COMITE DES CREANCIERSParis (France), 6 juillet 2020 – Technicolor (Euronext Paris : TCH ; OTCQX : TCLRY) (la « Société ») et la SELARL FHB, prise en les personnes de Maîtres Hélène Bourbouloux et Gael Couturier, en qualité d’administrateurs judiciaires nommés par le Tribunal de Commerce de Paris par jugement du 22 juin 2020 (l’« Administrateur Judiciaire »), annoncent que lors de la réunion qui s’est tenue le 5 juillet 2020 sur convocation de l’Administrateur Judicaire, le comité des établissements de crédit et assimilés (CECA) dans le cadre de la procédure de sauvegarde financière accélérée de la Société, a approuvé le projet de plan de sauvegarde à une majorité de 100% des votes exprimés.La Société se réjouit de la réussite de ce nouveau jalon, la prochaine étape-clé...

Continue reading

Inventiva announces the decision by the investigator to reduce the number of patients in the ongoing Phase II trial evaluating lanifibranor in type 2 diabetes patients (T2DM) with Non-Alcoholic Fatty Liver Disease (NAFLD)

Following higher than expected effects on steatosis reduction during the Phase IIb NATIVE trial in NASH, the number of patients to be recruited in the trial evaluating lanifibranor in patients with T2DM and NAFLD has been reduced to 34 (vs. 64 initially) The Phase II trial results are expected in 2021Daix (France), July 6, 2020 – Inventiva (Euronext: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced the decision by the investigator to reduce the number of patients to be enrolled in the investigator-initiated Phase II clinical trial of lanifibranor in patients with TD2M and NAFLD being...

Continue reading

Inventiva annonce la décision de l’investigateur de réduire le nombre de patients dans l’étude de Phase II en cours évaluant lanifibranor chez des patients atteints de diabète de type 2 (T2DM) et de stéatose hépatique non alcoolique (NAFLD)

A la suite des effets plus importants que prévus concernant la réduction de la stéatose lors de l’étude de Phase IIb NATIVE dans la NASH, le nombre de patients à recruter dans l’étude évaluant lanifibranor chez les patients atteints de T2DM et de NAFLD a été réduit à 34 (contre 64 initialement) Les résultats de l’étude de Phase II sont attendus en 2021Daix (France), le 6 juillet 2020 – Inventiva (Euronext Paris: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui la décision de l’investigateur de réduire le nombre de patients à recruter...

Continue reading

Dividend payment ex-date of AS Tallinna Sadam

AS Tallinna Sadam (trading code TSM1T, ISIN code EE3100021635) will close the list of shareholders entitled to receive dividends on 13 July 2020 at the end of the working day of the Nasdaq CSD settlement system.Consequently, the day of change of the rights related to the shares (ex-date) is set to 10 July 2020. From this day onwards, the person acquiring the shares will not have the right to receive dividends for the financial year 2019.AS Tallinna Sadam will pay dividend 0.115 euros per share on 20 July 2020.Marju ZirelHead of Investor RelationsAS Tallinna Sadamm.zirel@ts.ee

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.